HER2-positive Advanced Solid Tumor
3 clinical trials · Condition
◉ Watch HER2-positive Advanced Solid Tumor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors (NCT05150691) | DualityBio Inc. | 2022-01-31 |
| Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors (NCT05423977) | Hangzhou Adcoris Biopharmacy Co., Ltd | 2021-12-17 |
| Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors (NCT04450732) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2020-07-07 |
Track HER2-positive Advanced Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.